Browsing by Author "Garrido S., Marcelo"
Now showing 1 - 12 of 12
Results Per Page
Sort Options
- ItemA Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability(2020) Pinto Paganini, Mauricio Arturo; Bravo Castillo, Maria Loreto; Sánchez Rojel, César Giovanni; Acevedo, Francisco; Mondaca Contreras, Sebastián Patricio; Ibañez, Carolina; Galindo A., Héctor; Madrid Arenas, Jorge; Nervi Nattero, Bruno; Peña Durán, José Esteban; Torres Montes, Paula Javiera; Owen, Gareth Ivor; Corvalán R., Alejandro; Garrido S., Marcelo; Córdova Delgado, M.; Retamal, I. N.; Muñoz Medel, M.; Durán, D.; Villanueva, F.; Koch, E.; Armisen, R.
- ItemChallenges in first line chemotherapy and targeted therapy in advanced gastric cancer(2014) Garrido S., Marcelo; Fonseca, P.; Vieitez, J.; Frunza, M.; Lacave, A.
- ItemEfficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer : the KEYNOTE-062 phase 3 randomized clinical trial(2020) Shitara, K.; Van Cutsem, E.; Bang, Y. J.; Fuchs, C.; Wyrwicz, L.; Lee, K.W.; Kudaba, I.; Garrido S., Marcelo; Chung, H. C.; Lee, J.; Castro, H. R.; Mansoor, W.; Braghiroli, M. I.; Karaseva, N.; Caglevic, C.; Villanueva, L.; Goekkurt, E.; Satake, H.; Enzinger, P.; Alsina, M.; Benson, A.; Chao, J.; Ko, A. H.; Wainberg, Z. A.; Kher, U.; Shah, S.; Kang, S. P.; Tabernero, J.
- ItemHealth-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma : KEYNOTE-240(2021) Ryoo, B. Y.; Merle, P.; Kulkarni, A. S.; Cheng, A. L.; Bouattour, M.; Lim, H. Y.; Breder, V.; Edeline, J.; Chao, Y.; Garrido S., Marcelo; Ogasawara, S.; Yau, T.; Chan, S. L.; Daniele, B.; Norquist, J. M.; Chen, E.; Siegel, A. B.; Zhu, A. X.; Finn, R. S.; Kudo, M.
- ItemMultistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer(2019) Carmona-Bayonas, A.; Jimenez-Fonseca, P.; Garrido S., Marcelo; Custodio, A.; Hernandez, R.; Lacalle, A.; Cano, J.M.; Aguado, G.; De Castro, E.M.; Mancenido, F.A.; Macias, I.; Visa, L.; Richard, M.M.; Mangas, M.; Canovas, M.S.; Longo, F.; Rey, L.I.; Lago, N.M.; Carnicero, A.M.; Sanchez, A.; Azkarate, A.; Limon, M.L.; Perez, C.H.; Ramchandani, A.; Pimentel, P.; Cerda, P.; Serrano, R.; Gil-Negrete, A.; Marin, M.; Hurtado, A.; Bayona, R.S.; Gallego, J.
- ItemPembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma : results from the phase II nonrandomized KEYNOTE-059 study(2019) Bang, Y.J.; Kang, Y.K.; Catenacci, D.V.; Muro, K.; Fuchs, C.S.; Geva, R.; Hara, H.; Golan, T.; Garrido S., Marcelo; Jalal, S.I.; Borg, C.; Doi, T.; Yoon, H.H.; Savage, M.J.; Wang, J.; Dalal, R.P.; Shah, S.; Wainberg, Z.A.; Chung, H.C.
- ItemPembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010) : a randomised controlled trial(2016) Herbst, Roy S.; Baas, Paul; Kim, Dong-Wan; Felip, Enriqueta; Pérez-Gracia, José L.; Han, Ji-YouN.; Molina, Julián; Kim, Joo-Hang; Dubos Arvis, Catherine; Garrido S., Marcelo
- ItemPerformance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors(2017) Garrido S., Marcelo; Carmona Bayonas, Alberto; Jiménez Fonseca, P.; Virizuela Echaburu, J.A.; Antonio, Maite; Font Puig, Carme; Biosca Gomez de Tejada, Mercedes; Ramchandani Vaswani, Avi; Martinez Garcia, Jerónimo; Hernando Cubero, Jorge; Espinosa Arranz, Javier; Martínez de Castro, Eva; Ghanem, I.; Beato, C.; Blasco, A.; Mondéjar, R.
- ItemRuxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy : JANUS 1 and 2 randomized phase III studies(2018) Hurwitz, Herbert; Van Cutsem, Eric; Bendell, Johanna; Hidalgo, Manuel; Chung-Pin Li; Garrido S., Marcelo; Macarulla, Teresa; Sahai, Vaibhav; Sama, Ashwin; Greeno, Edward
- ItemSafety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial(2018) Fuchs, C. S.; Doi, T.; Jang, R. W.; Muro, K.; Satoh, T.; Machado, M.; Sun, W.; Jalal, S. I.; Shah, M. A.; Garrido S., Marcelo; Metges, J. P.
- ItemSurgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry(2018) Carmona Bayonas, Alberto; Jiménez Fonseca, Paula; Echavarría, Isabel; Sánchez Cánovas, Manuel; Aguado, Gema; Gallego, Javier; Custodio, Ana; Raquel Hernández, Raquel; Viudez, Antonio; Garrido S., Marcelo; et al.
- ItemThe reprimo-like gene is an epigenetic-mediated tumor suppressor and a candidate biomarker for the non-invasive detection of gastric cancer(2020) Alarcón Alarcón, María Alejandra; Olivares, W.; Córdova Delgado, M.; Wichmann Pérez, Ignacio Alberto; Amigo, Julio; Norero Muñoz, Enrique; Riquelme Pérez, Arnoldo; Garrido S., Marcelo; Owen, Gareth Ivor; Corvalán R., Alejandro; Muñoz-Medel, M.; Mayo, T. de; Carrasco-Aviño, G.; Landeros, N.; Villarroel Espíndola, F.